Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | yes | yes: 6 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 | 
| NetGPI | no | yes: 0, no: 11 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 1 | 
| GO:0043226 | organelle | 2 | 1 | 
| GO:0043227 | membrane-bounded organelle | 3 | 1 | 
| GO:0043229 | intracellular organelle | 3 | 1 | 
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 | 
| GO:0110165 | cellular anatomical entity | 1 | 1 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| 
                        
                            Lahav et al. - mRNA 
                            - Protein 
                        
                     | 
                    
Related structures:
AlphaFold database: A4HVI1
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 | 
| GO:0006351 | DNA-templated transcription | 7 | 1 | 
| GO:0006366 | transcription by RNA polymerase II | 8 | 1 | 
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 | 
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 | 
| GO:0008152 | metabolic process | 1 | 1 | 
| GO:0009058 | biosynthetic process | 2 | 1 | 
| GO:0009059 | macromolecule biosynthetic process | 4 | 1 | 
| GO:0009987 | cellular process | 1 | 1 | 
| GO:0016070 | RNA metabolic process | 5 | 1 | 
| GO:0018130 | heterocycle biosynthetic process | 4 | 1 | 
| GO:0019438 | aromatic compound biosynthetic process | 4 | 1 | 
| GO:0032774 | RNA biosynthetic process | 5 | 1 | 
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 | 
| GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 | 
| GO:0043170 | macromolecule metabolic process | 3 | 1 | 
| GO:0044237 | cellular metabolic process | 2 | 1 | 
| GO:0044238 | primary metabolic process | 2 | 1 | 
| GO:0044249 | cellular biosynthetic process | 3 | 1 | 
| GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 | 
| GO:0046483 | heterocycle metabolic process | 3 | 1 | 
| GO:0071704 | organic substance metabolic process | 2 | 1 | 
| GO:0090304 | nucleic acid metabolic process | 4 | 1 | 
| GO:0097659 | nucleic acid-templated transcription | 6 | 1 | 
| GO:1901360 | organic cyclic compound metabolic process | 3 | 1 | 
| GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 | 
| GO:1901576 | organic substance biosynthetic process | 3 | 1 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003712 | transcription coregulator activity | 2 | 1 | 
| GO:0003713 | transcription coactivator activity | 3 | 1 | 
| GO:0140110 | transcription regulator activity | 1 | 1 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 182 | 186 | PF00656 | 0.516 | 
| CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.242 | 
| CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.582 | 
| CLV_NRD_NRD_1 | 252 | 254 | PF00675 | 0.484 | 
| CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.230 | 
| CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.230 | 
| CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.559 | 
| CLV_PCSK_KEX2_1 | 252 | 254 | PF00082 | 0.490 | 
| CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.503 | 
| CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.478 | 
| CLV_PCSK_PC1ET2_1 | 191 | 193 | PF00082 | 0.242 | 
| CLV_PCSK_PC1ET2_1 | 56 | 58 | PF00082 | 0.549 | 
| CLV_PCSK_PC1ET2_1 | 73 | 75 | PF00082 | 0.400 | 
| CLV_PCSK_PC7_1 | 187 | 193 | PF00082 | 0.230 | 
| CLV_PCSK_PC7_1 | 21 | 27 | PF00082 | 0.598 | 
| CLV_PCSK_PC7_1 | 69 | 75 | PF00082 | 0.616 | 
| CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.590 | 
| CLV_PCSK_SKI1_1 | 143 | 147 | PF00082 | 0.597 | 
| CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.335 | 
| CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.488 | 
| DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.657 | 
| DOC_USP7_UBL2_3 | 194 | 198 | PF12436 | 0.546 | 
| DOC_USP7_UBL2_3 | 274 | 278 | PF12436 | 0.681 | 
| DOC_USP7_UBL2_3 | 48 | 52 | PF12436 | 0.491 | 
| DOC_USP7_UBL2_3 | 62 | 66 | PF12436 | 0.478 | 
| DOC_USP7_UBL2_3 | 87 | 91 | PF12436 | 0.554 | 
| DOC_USP7_UBL2_3 | 99 | 103 | PF12436 | 0.435 | 
| DOC_WW_Pin1_4 | 228 | 233 | PF00397 | 0.455 | 
| LIG_14-3-3_CanoR_1 | 13 | 20 | PF00244 | 0.584 | 
| LIG_14-3-3_CanoR_1 | 143 | 148 | PF00244 | 0.586 | 
| LIG_14-3-3_CanoR_1 | 216 | 224 | PF00244 | 0.456 | 
| LIG_14-3-3_CanoR_1 | 41 | 49 | PF00244 | 0.534 | 
| LIG_Actin_WH2_2 | 201 | 218 | PF00022 | 0.535 | 
| LIG_deltaCOP1_diTrp_1 | 222 | 228 | PF00928 | 0.431 | 
| LIG_EH_1 | 233 | 237 | PF12763 | 0.442 | 
| LIG_FHA_1 | 238 | 244 | PF00498 | 0.414 | 
| LIG_FHA_2 | 161 | 167 | PF00498 | 0.452 | 
| LIG_LIR_Gen_1 | 218 | 227 | PF02991 | 0.467 | 
| LIG_LIR_Nem_3 | 218 | 223 | PF02991 | 0.467 | 
| LIG_PCNA_yPIPBox_3 | 216 | 228 | PF02747 | 0.442 | 
| LIG_PCNA_yPIPBox_3 | 91 | 105 | PF02747 | 0.456 | 
| LIG_SH2_GRB2like | 10 | 13 | PF00017 | 0.601 | 
| LIG_SH2_STAP1 | 201 | 205 | PF00017 | 0.496 | 
| LIG_SH2_STAT5 | 10 | 13 | PF00017 | 0.601 | 
| LIG_SH3_3 | 120 | 126 | PF00018 | 0.613 | 
| LIG_SH3_3 | 229 | 235 | PF00018 | 0.455 | 
| LIG_SH3_3 | 83 | 89 | PF00018 | 0.546 | 
| LIG_TRAF2_1 | 151 | 154 | PF00917 | 0.581 | 
| LIG_TYR_ITSM | 216 | 223 | PF00017 | 0.535 | 
| LIG_UBA3_1 | 223 | 230 | PF00899 | 0.455 | 
| MOD_CK2_1 | 256 | 262 | PF00069 | 0.689 | 
| MOD_CMANNOS | 225 | 228 | PF00535 | 0.230 | 
| MOD_Cter_Amidation | 189 | 192 | PF01082 | 0.230 | 
| MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.613 | 
| MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.262 | 
| MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.197 | 
| MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.555 | 
| MOD_GSK3_1 | 154 | 161 | PF00069 | 0.320 | 
| MOD_N-GLC_1 | 175 | 180 | PF02516 | 0.338 | 
| MOD_NEK2_1 | 215 | 220 | PF00069 | 0.442 | 
| MOD_PIKK_1 | 215 | 221 | PF00454 | 0.432 | 
| MOD_PKA_2 | 12 | 18 | PF00069 | 0.575 | 
| MOD_PKA_2 | 215 | 221 | PF00069 | 0.455 | 
| MOD_PKA_2 | 40 | 46 | PF00069 | 0.615 | 
| MOD_PKB_1 | 141 | 149 | PF00069 | 0.464 | 
| MOD_Plk_1 | 110 | 116 | PF00069 | 0.540 | 
| MOD_Plk_2-3 | 256 | 262 | PF00069 | 0.617 | 
| MOD_ProDKin_1 | 228 | 234 | PF00069 | 0.455 | 
| MOD_SUMO_for_1 | 124 | 127 | PF00179 | 0.714 | 
| MOD_SUMO_for_1 | 208 | 211 | PF00179 | 0.491 | 
| MOD_SUMO_rev_2 | 43 | 50 | PF00179 | 0.487 | 
| MOD_SUMO_rev_2 | 58 | 68 | PF00179 | 0.393 | 
| TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.430 | 
| TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.451 | 
| TRG_ER_diArg_1 | 215 | 217 | PF00400 | 0.455 | 
| TRG_ER_diArg_1 | 25 | 27 | PF00400 | 0.589 | 
| TRG_ER_diArg_1 | 252 | 254 | PF00400 | 0.480 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1I1R4 | Leptomonas seymouri | 69% | 100% | 
| A0A0S4JL95 | Bodo saltans | 45% | 100% | 
| A0A1X0NNI4 | Trypanosomatidae | 54% | 100% | 
| A0A3R7NKC3 | Trypanosoma rangeli | 53% | 100% | 
| A0A3S7WSF4 | Leishmania donovani | 100% | 100% | 
| A4H741 | Leishmania braziliensis | 83% | 100% | 
| D0A6T0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% | 
| E9AP76 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% | 
| Q28HN4 | Xenopus tropicalis | 29% | 100% | 
| Q4QGA2 | Leishmania major | 94% | 100% | 
| Q54GW3 | Dictyostelium discoideum | 30% | 100% | 
| Q68EY7 | Xenopus laevis | 29% | 100% | 
| Q6DD17 | Xenopus laevis | 30% | 100% | 
| Q6PHE8 | Danio rerio | 28% | 100% | 
| V5BAV6 | Trypanosoma cruzi | 54% | 91% |